Panagora Asset Management’s Abeona Therapeutics ABEO Stock Holding History

Panagora Asset Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.53M	Buy	409,075 +209,930	+105%	+$1.15M	0.01%	588
2026 Q1	$892K	Buy	199,145 +32,434	+19%	+$162K	﹤0.01%	734
2025 Q4	$879K	Buy	166,711 +6,154	+4%	+$31K	﹤0.01%	755
2025 Q3	$848K	Buy	+160,557	New	+$1.02M	﹤0.01%	693
2021 Q3	–	Sell	-105	Closed	-$4K	–	1696
2021 Q2	$4K	Sell	105 -687	-87%	-$28K	﹤0.01%	2514
2021 Q1	$37K	Buy	792 +687	+654%	+$37.8K	﹤0.01%	2234
2020 Q4	$4K	Buy	+105	New	+$3.58K	﹤0.01%	2504
2020 Q3	–	Sell	-145	Closed	-$11K	–	2690
2020 Q2	$11K	Buy	+145	New	+$10K	﹤0.01%	2230

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OIA

OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Panagora Asset Management's ABEO Position: Q2 2026 in Review

Panagora Asset Management increased its Abeona Therapeutics (ABEO) stake by 105% in Q2 2026, buying an estimated $1.15M and bringing the position to 409,075 shares worth $2.53M. The position accounts for 0.01% of the portfolio, ranked #588.

Panagora Asset Management first reported a position in ABEO in Q2 2020 and has held it in 8 quarters since. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

Panagora Asset Management held 409,075 shares of Abeona Therapeutics worth $2.53M as of Q2 2026.
Panagora Asset Management bought 209,930 Abeona Therapeutics shares in Q2 2026, an estimated $1.15M.
Abeona Therapeutics made up 0.01% of Panagora Asset Management's portfolio in Q2 2026, its #588 holding.
Panagora Asset Management first reported a position in Abeona Therapeutics in Q2 2020 and has held it in 8 quarters since.
126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.